Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020
News
UK dementia clinical trial participation set to boost by ‘tens of thousands’
The new Dementia Trials Accelerator is set to receive £20m of government funding
WHO report highlights resurgence of tuberculosis
Approximately 8.2 million people were diagnosed with the infectious disease in 2023
NICE recommendation for new Alexion PNH treatment
danicopan shown to improve haemoglobin levels and reduce anaemia
Darzalex subcutaneous regimen approved by European Commission
New treatment option for patients with newly diagnosed multiple myeloma
Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug
CAL101 shows promising results and is set to enter phase 2 development
Valneva Scotland announces year-long support for local cancer charity Team Jak
The company’s workforce will volunteer and fundraise for Team Jak throughout the year
NICE recommends Santen’s Roclanda to treat glaucoma and ocular hypertension
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK
Learna and University of Wolverhampton launch flexible healthcare courses
The five new programmes are designed to fit alongside full-time work and clinical practice
New £4.5m initiative launched to address UK medicines manufacturing skills shortage
The two-year programme will use virtual reality technology to teach essential skills
Vivan renews five-year lease at UK biotech hub White City Place
The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma
HBC Immunology shares promising results for prostate cancer co-therapy
There are around 55,100 new prostate cancer cases in the UK every year
Celltrion unveils promising dose escalation results for subcutaneous infliximab
Study reveals potential new strategy for managing inflammatory bowel disease
Alleo and Ubiquigent unite to accelerate drug discovery
Partnership to harness AI for DUB-focused preclinical programmes
Lundbeck to acquire Longboard Pharmaceuticals in strategic deal
Acquisition to enhance Lundbeck’s neuroscience pipeline
